Literature DB >> 2405316

Cesarean prophylaxis: a comparison of cefamandole and cefazolin by both intravenous and lavage routes, and risk factors associated with endometritis.

C M Peterson1, M Medchill, D S Gordon, H L Chard.   

Abstract

This study included 207 patients in a double-blind, prospective randomized trial of cefazolin versus cefamandole single-dose prophylaxis by both intravenous (IV) and lavage routes in patients laboring with ruptured membranes who eventually had nonelective cesareans. No significant differences (P less than .05) were noted in the rates of infectious morbidity (cefazolin IV: six of 47, 13%; cefazolin lavage: nine of 59, 15%; cefamandole IV: six of 47, 13%; cefamandole lavage: six of 54, 11%). The incidence of operative complications in the patients developing endometritis (eight of 22, 36%) was significantly different (P less than .004) from that in the group who did not develop endometritis (21 of 185, 11%). Cefazolin by IV and lavage routes of administration appears to be as effective as cefamandole by either route of administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405316

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Intracavity lavage and wound irrigation for prevention of surgical site infection.

Authors:  Gill Norman; Ross A Atkinson; Tanya A Smith; Ceri Rowlands; Amber D Rithalia; Emma J Crosbie; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

Review 2.  Different classes of antibiotics given to women routinely for preventing infection at caesarean section.

Authors:  Gillian M I Gyte; Lixia Dou; Juan C Vazquez
Journal:  Cochrane Database Syst Rev       Date:  2014-11-17

3.  Different classes of antibiotics given to women routinely for preventing infection at caesarean section.

Authors:  Myfanwy J Williams; Carolina Carvalho Ribeiro do Valle; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.